Moderna Inc (MRNA)
125.65
+14.19
(+12.73%)
USD |
NASDAQ |
May 02, 16:00
124.33
-1.32
(-1.05%)
After-Hours: 18:36
Moderna Cash from Investing (Quarterly): -538.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -538.00M |
September 30, 2023 | 789.00M |
June 30, 2023 | 1.944B |
March 31, 2023 | 2.011B |
December 31, 2022 | -1.048B |
September 30, 2022 | 945.00M |
June 30, 2022 | -1.152B |
March 31, 2022 | -3.921B |
December 31, 2021 | -1.138B |
September 30, 2021 | -3.327B |
June 30, 2021 | -3.878B |
March 31, 2021 | -180.00M |
Date | Value |
---|---|
December 31, 2020 | -190.00M |
September 30, 2020 | -1.179B |
June 30, 2020 | 13.00M |
March 31, 2020 | -316.00M |
December 31, 2019 | 130.29M |
September 30, 2019 | 113.37M |
June 30, 2019 | -246.90M |
March 31, 2019 | -11.76M |
December 31, 2018 | 6.173M |
September 30, 2018 | 116.08M |
June 30, 2018 | -11.64M |
March 31, 2018 | -483.70M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.921B
Minimum
Mar 2022
2.011B
Maximum
Mar 2023
-587.80M
Average
-246.90M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
Eli Lilly and Co | -1.178B |
Merck & Co Inc | 53.00M |
Pfizer Inc | -11.00B |
Johnson & Johnson | -464.00M |
Novavax Inc | -9.078M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 622.00M |
Cash from Financing (Quarterly) | -109.00M |
Free Cash Flow | -3.825B |
Free Cash Flow Per Share (Quarterly) | 1.052 |
Free Cash Flow to Equity (Quarterly) | 402.00M |
Free Cash Flow to Firm (Quarterly) | 402.00M |
Free Cash Flow Yield | -7.86% |